| scholarly article | Q13442814 |
| P50 | author | Stéphanie Simon | Q89013039 |
| P2093 | author name string | Marc Plaisance | |
| Julie Dano | |||
| Karine Moreau | |||
| Bakhos Jneid | |||
| Audrey Rouaix | |||
| P2860 | cites work | Complete genome sequence of Salmonella enterica serovar Typhimurium LT2 | Q22122369 |
| Vaccines for preventing typhoid fever | Q24201238 | ||
| The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children | Q24651695 | ||
| Salmonella pathogenicity island 2 is expressed prior to penetrating the intestine | Q24811102 | ||
| Genome-wide screen for Salmonella genes required for long-term systemic infection of the mouse | Q25257713 | ||
| A new and rapid colorimetric determination of acetylcholinesterase activity | Q26778487 | ||
| Global burden of invasive nontyphoidal Salmonella disease, 2010(1) | Q26828546 | ||
| Assembly and structure of the T3SS | Q26865556 | ||
| Live attenuated vaccines for invasive Salmonella infections | Q27003066 | ||
| Vaccines against invasive Salmonella disease: current status and future directions | Q27007088 | ||
| Antimicrobial resistance and management of invasive Salmonella disease | Q28080658 | ||
| Protective host immune responses to Salmonella infection | Q28087452 | ||
| Global trends in typhoid and paratyphoid Fever | Q28267865 | ||
| Protein delivery into eukaryotic cells by type III secretion machines | Q28276443 | ||
| Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas | Q28308143 | ||
| Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages | Q28563572 | ||
| The type III secretion injectisome | Q29617944 | ||
| Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells | Q33608920 | ||
| Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans | Q33733849 | ||
| Evolution of host adaptation in Salmonella enterica | Q33764112 | ||
| Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium | Q34004688 | ||
| Salmonella enterica replication in hemophagocytic macrophages requires two type three secretion systems | Q34045086 | ||
| Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. | Q34275116 | ||
| Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study | Q34345075 | ||
| Salmonella interactions with host cells: type III secretion at work | Q34425135 | ||
| Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen | Q34515039 | ||
| Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi | Q34559735 | ||
| Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates. | Q34760675 | ||
| Development of acquired immunity to Salmonella | Q35128104 | ||
| Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis | Q35201533 | ||
| Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis | Q35272921 | ||
| Methodologies for Salmonella enterica subsp. enterica subtyping: gold standards and alternatives | Q35530188 | ||
| Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. | Q36363455 | ||
| Multiplicity of Salmonella entry mechanisms, a new paradigm for Salmonella pathogenesis. | Q36395663 | ||
| MHC class-I-restricted CD8 T cells play a protective role during primary Salmonella infection. | Q36518258 | ||
| Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium | Q36944529 | ||
| Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. | Q36966451 | ||
| Salmonellae interplay with host cells | Q37008201 | ||
| Structure and biophysics of type III secretion in bacteria | Q37014297 | ||
| Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD. | Q37032264 | ||
| Salmonella infections in immunocompromised adults | Q37161757 | ||
| The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response | Q37239010 | ||
| Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype | Q37471898 | ||
| Visiting the cell biology of Salmonella infection | Q37764171 | ||
| Immunity to salmonellosis | Q37846872 | ||
| Salmonella T3SSs: successful mission of the secret(ion) agents. | Q38072180 | ||
| Emergence of Community-Acquired, Multidrug-Resistant Invasive Nontyphoidal Salmonella Disease in Rural Western Kenya, 2009-2013. | Q38602713 | ||
| Nontyphoidal salmonella disease: Current status of vaccine research and development | Q40111788 | ||
| Structural analysis of the O-acetylated O-polysaccharide isolated from Salmonella paratyphi A and used for vaccine preparation | Q40170251 | ||
| Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine | Q40577238 | ||
| Morphological and cytoskeletal changes in epithelial cells occur immediately upon interaction with Salmonella typhimurium grown under low-oxygen conditions | Q41596545 | ||
| Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials | Q43421493 | ||
| Primary macrophages from HIV-infected adults show dysregulated cytokine responses to Salmonella, but normal internalization and killing | Q46815843 | ||
| Bacteremia among children admitted to a rural hospital in Kenya | Q50094121 | ||
| Intracellular replication of Salmonella typhimurium strains in specific subsets of splenic macrophages in vivo. | Q50113387 | ||
| Biogenesis of Salmonella typhimurium-containing vacuoles in epithelial cells involves interactions with the early endocytic pathway | Q50117184 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | infectious disease | Q18123741 |
| Salmonella Typhimurium | Q166491 | ||
| P304 | page(s) | e0005207 | |
| P577 | publication date | 2016-12-19 | |
| P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
| P1476 | title | Role of T3SS-1 SipD Protein in Protecting Mice against Non-typhoidal Salmonella Typhimurium | |
| P478 | volume | 10 |
| Q98160163 | Overview of the Nontyphoidal and Paratyphoidal Salmonella Vaccine Pipeline: Current Status and Future Prospects |
| Q64234386 | Promises and Challenges of the Type Three Secretion System Injectisome as an Antivirulence Target |
| Q64102270 | Structural and Functional Characterization of the Type Three Secretion System (T3SS) Needle of |
Search more.